TY - JOUR
T1 - Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening
AU - Papanicolas, Lito E.
AU - Gordon, David L.
AU - Wesselingh, Steve L.
AU - Rogers, Geraint B.
PY - 2020/5
Y1 - 2020/5
N2 - Faecal microbiota transplantation (FMT) has been shown to be effective in the treatment of a growing number of conditions, and its clinical use continues to rise. However, recent cases of antibiotic-resistant pathogen transmission through FMT, resulting in at least one case of fatal sepsis, highlight the need to reevaluate current donor screening practices. Commensal gut microbes profoundly influence infection risk but are not routinely assessed in donor stool. Extending the assessment of donor material beyond pathogen populations to include the composition and structure of the wider faecal microbiota has the potential to reduce infectious complications in FMT recipients.
AB - Faecal microbiota transplantation (FMT) has been shown to be effective in the treatment of a growing number of conditions, and its clinical use continues to rise. However, recent cases of antibiotic-resistant pathogen transmission through FMT, resulting in at least one case of fatal sepsis, highlight the need to reevaluate current donor screening practices. Commensal gut microbes profoundly influence infection risk but are not routinely assessed in donor stool. Extending the assessment of donor material beyond pathogen populations to include the composition and structure of the wider faecal microbiota has the potential to reduce infectious complications in FMT recipients.
KW - faecal microbiota transplantation
KW - infection
KW - microbiome
KW - sepsis
UR - http://www.scopus.com/inward/record.url?scp=85077927795&partnerID=8YFLogxK
U2 - 10.1016/j.tim.2019.12.009
DO - 10.1016/j.tim.2019.12.009
M3 - Review article
AN - SCOPUS:85077927795
SN - 0966-842X
VL - 28
SP - 331
EP - 339
JO - Trends in Microbiology
JF - Trends in Microbiology
IS - 5
M1 - TIMI 1773
ER -